Company intelligence / Profile preview

Florida Biologics

Alachua, Florida, United States

Ownership: Private
Development stage: Other

Overview

Florida Biologics was a contract development and manufacturing organization (CDMO) specializing in the production of biologics and viral vectors for gene therapy. Based in Alachua, Florida, the company provided process development and clinical-stage manufacturing services to biotechnology and pharmaceutical clients. In 2016, Florida Biologics was acquired by Brammer Bio, which sought to expand its capacity for cell and gene therapy manufacturing. Brammer Bio was subsequently acquired by Thermo Fisher Scientific in 2019, and the Florida Biologics facilities now operate as part of Thermo Fisher's Viral Vector Services division.

Modalities: BiologicGene therapyViral vector
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Florida Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Florida Biologics.

Explore the full profile